Avatar 1Avatar 2Avatar 3Avatar 4Avatar 5

Earn 10$ Cash for every Pro+ Friend you Refer!

Intellia Therapeutics Inc

Intellia Therapeutics Inc

NTLA · NASDAQ
NTLA · NASDAQ

Next Earnings: 31 Jul 2025

10.26
USD-0.44-4.11%

Latest News

    @DeItaone
    DeItaone

    Coverage Initiated $EDIT $GIS $NTLA $RCKT $ROL $SHOP $VERV https://t.co/HsvywOztkC https://t.co/vPxyRE3iIJ

      @DeItaone
      DeItaone

      Upgrades https://t.co/eAzzXmW2uv $BX $HASI $IBM $LYFT $MRO $NTLA $XYL https://t.co/c9MtCpeWvz

        @cryptomocho
        cryptomocho

        added only bio stunks to my porfolio and tesla $NTLA $BEAM $CRSP $EDIT $VERV $DNA $ADAP and my bigest one $intx https://t.co/jy9Q2ROAnB

          SeekingAlpha

          Intellia Therapeutics, Alnylam seen as potential Regeneron targets, analyst says

            CNBC

            Stocks making the biggest moves in the premarket: Boeing, Intellia Therapeutics, Perion Network & more - CNBC

              @Zero_Hegde
              Zero_Hegde

              RT @_B_I_O_T_E_C_H_: Leerink: #Gene #Editing Companies YTD Returns $SGMO way to go , $NTLA $EDIT $CRSP https://t.co/6opf7EfaMG

              Analysts Recommendations

              Bullish

              Buy

              Strong Buy

              Buy

              Hold

              Sell

              Strong Sell

              Day Range

              10.18USD
              10.82USD

              52 Week Range

              5.90USD
              28.18USD

              Market Cap

              1.11BUSD

              lock-imagelock-image

              Get Full Access with Profit PRO

              See which Billionaires own this investment

              About

              General Information

              Type

              Common Stock

              Exchange

              NASDAQ

              Currency Code

              USD

              Currency Name

              US Dollar

              Country Name

              USA

              Country ISO

              US

              ISIN

              US45826J1051

              CUSIP

              45826J105

              Sector

              Healthcare

              Industry

              Biotechnology

              Fiscal Year End

              December

              IPO date

              -

              Updated At

              -

              Highlights

              PE Ratio

              -

              PEG Ratio

              -0.10

              Book Value

              7.53

              Dividend Share

              -

              Dividend Yield

              -

              Earnings Share

              -5.23

              Wall Street Target Price

              37.30

              EPS Estimate Current Year

              -4.16

              EPS Estimate Next Year

              -3.86

              EPS Estimate Current Quarter

              -1.2711

              EPS Estimate Next Quarter

              -1.1578

              Most Recent Quarter

              -

              Profitability

              Revenue TTM

              45,569,000

              Gross Profit TTM

              -417,321,984

              EBITDA

              -530,796,000

              Profit Margin

              0.00%

              Return On Assets TTM

              -30.12%

              Return On Equity TTM

              -57.92%

              Revenue Per Share TTM

              0.452

              Qtly Revenue Growth YOY

              -42.50%

              Diluted Eps TTM

              -5.23

              Qtly Earnings Growth YOY

              0.00%

              Valuation

              Trailing PE

              0.00

              Forward PE

              0

              Price Sales TTM

              23.2993

              Price Book MRQ

              1.3613

              Enterprise Value Revenue

              14

              Enterprise Value EBITDA

              -5

              Peers analysis

              • UCB SA ADR
                UCBJYUCB SA ADR

                99.35

                3.29%
              • UCB SA
                UCBJFUCB SA

                203.85

                2.01%
              • CSL Ltd
                CSLLYCSL Ltd

                80.40

                0.55%
              • CSL Limited
                CMXHFCSL Limited

                152.82

                0.06%
              • Regeneron Pharmaceuticals Inc
                REGNRegeneron Pharmaceuticals Inc

                538.11

                0.04%
              • argenx SE
                ARGNFargenx SE

                547.60

                0.00%
              • Be
                ONCBeiGene, Ltd.

                240.50

                -2.03%
              • argenx NV ADR
                ARGXargenx NV ADR

                545.20

                -0.21%
              • Alnylam Pharmaceuticals Inc
                ALNYAlnylam Pharmaceuticals Inc

                324.00

                -0.05%
              • Vertex Pharmaceuticals Inc
                VRTXVertex Pharmaceuticals Inc

                459.50

                -0.00%
              XM

              Trade Stocks with $30 Free + Double your Deposits with a 100% Bonus

              Trade with a Trusted, Award-Winning Broker.

              Trading involves risk. The value of investments may go up or down. Trade responsibly.

              FAQs

              What is Intellia Therapeutics stock price today?

              What is Intellia Therapeutics stock ticker?

              Is NTLA stock price going up?

              What is the analyst recommendation for NTLA?

              What is NTLA market cap?

              Does NTLA release financial reports?

              When is NTLA next earnings date?

              What were NTLA Earnings for the last quarter?

              What was NTLA Revenue for the last quarter?

              What was NTLA Net Income for the last quarter?

              Does NTLA pay dividends?

              How many employees does NTLA have?

              What is NTLA EBITDA?

              How to buy NTLA stocks?

              Should I invest in NTLA stock?